Lumanity
@lumanity.bsky.social
We revolutionize how value is generated, demonstrated, and communicated to unlock the full potential of your brand and your company
Want the five key themes shaping the future of breast cancer care? Check out our perspective from the San Antonio Breast Cancer Symposium (SABCS) 2025.
Read the insights, data highlights, and actionable recommendations: lumanity.com?post_type=pe....
#SABCS2025 #BreastCancer #Patients
Read the insights, data highlights, and actionable recommendations: lumanity.com?post_type=pe....
#SABCS2025 #BreastCancer #Patients
February 10, 2026 at 8:01 AM
Want the five key themes shaping the future of breast cancer care? Check out our perspective from the San Antonio Breast Cancer Symposium (SABCS) 2025.
Read the insights, data highlights, and actionable recommendations: lumanity.com?post_type=pe....
#SABCS2025 #BreastCancer #Patients
Read the insights, data highlights, and actionable recommendations: lumanity.com?post_type=pe....
#SABCS2025 #BreastCancer #Patients
Long-term success of cell and gene therapies depends on adapting as new challenges emerge after launch. Catch our upcoming webinar to gain practical strategies for market access, evidence generation, and adoption in rare and ultra-orphan therapies buff.ly/jaNXeFo
February 9, 2026 at 8:28 PM
Long-term success of cell and gene therapies depends on adapting as new challenges emerge after launch. Catch our upcoming webinar to gain practical strategies for market access, evidence generation, and adoption in rare and ultra-orphan therapies buff.ly/jaNXeFo
In our latest case study, we looked at moving a leading biopharmaceutical company beyond multichannel marketing to deliver personalized and synchronized experiences for healthcare providers: buff.ly/CBelyjj
#OmnichannelMarketing #LifeSciences #HCPEngagement #DataDriven
#OmnichannelMarketing #LifeSciences #HCPEngagement #DataDriven
February 6, 2026 at 4:00 PM
In our latest case study, we looked at moving a leading biopharmaceutical company beyond multichannel marketing to deliver personalized and synchronized experiences for healthcare providers: buff.ly/CBelyjj
#OmnichannelMarketing #LifeSciences #HCPEngagement #DataDriven
#OmnichannelMarketing #LifeSciences #HCPEngagement #DataDriven
The European Medicines Agency (EMA) recently released a draft of their ‘Reflection Paper on Patient Experience Data’ and invited public consultation. Check out our comments and recommendations from our Strategic Patient Council: buff.ly/3VpZAqj
February 5, 2026 at 8:02 PM
The European Medicines Agency (EMA) recently released a draft of their ‘Reflection Paper on Patient Experience Data’ and invited public consultation. Check out our comments and recommendations from our Strategic Patient Council: buff.ly/3VpZAqj
AI has rewritten the rules of #DigitalDiscovery. Instead of links, #AI assistants deliver direct answers — meaning if your brand isn’t cited, you’re invisible. The solution? Master the Engine #Optimization Trifecta: buff.ly/LWYfAnD
#SEO #AEO #GEO #DigitalVisibility
#SEO #AEO #GEO #DigitalVisibility
February 3, 2026 at 4:00 PM
AI has rewritten the rules of #DigitalDiscovery. Instead of links, #AI assistants deliver direct answers — meaning if your brand isn’t cited, you’re invisible. The solution? Master the Engine #Optimization Trifecta: buff.ly/LWYfAnD
#SEO #AEO #GEO #DigitalVisibility
#SEO #AEO #GEO #DigitalVisibility
Together with #Lareb, we explored whether #COVID19 vaccination in the Netherlands was followed by more GP consultations for venous thromboembolism (#VTE) — blood clots in veins. Read the full study: lumanity.com/perspectives...
#Vaccines #Pharmacovigilance #PublicHealth
#Vaccines #Pharmacovigilance #PublicHealth
February 3, 2026 at 8:00 AM
Together with #Lareb, we explored whether #COVID19 vaccination in the Netherlands was followed by more GP consultations for venous thromboembolism (#VTE) — blood clots in veins. Read the full study: lumanity.com/perspectives...
#Vaccines #Pharmacovigilance #PublicHealth
#Vaccines #Pharmacovigilance #PublicHealth
The #MarketResearch industry is undergoing seismic shifts, but the challenges also create opportunities to work smarter, go deeper, and be faster. Check out our client survey key findings highlighting evolving needs and insights into the future of the industry
lumanity.com/perspectives...
lumanity.com/perspectives...
January 28, 2026 at 12:01 PM
The #MarketResearch industry is undergoing seismic shifts, but the challenges also create opportunities to work smarter, go deeper, and be faster. Check out our client survey key findings highlighting evolving needs and insights into the future of the industry
lumanity.com/perspectives...
lumanity.com/perspectives...
We’re live at ISMPP EU 2026!
Come meet our experts at stand #5 and check out poster #25 tomorrow to discover smarter, more impactful ways to reach European oncologists with the data they need.
#ISMPP #ISMPPEurope #MedPubs #Oncology #ScientificComms #HCPEngagement
Come meet our experts at stand #5 and check out poster #25 tomorrow to discover smarter, more impactful ways to reach European oncologists with the data they need.
#ISMPP #ISMPPEurope #MedPubs #Oncology #ScientificComms #HCPEngagement
January 26, 2026 at 8:02 PM
We’re live at ISMPP EU 2026!
Come meet our experts at stand #5 and check out poster #25 tomorrow to discover smarter, more impactful ways to reach European oncologists with the data they need.
#ISMPP #ISMPPEurope #MedPubs #Oncology #ScientificComms #HCPEngagement
Come meet our experts at stand #5 and check out poster #25 tomorrow to discover smarter, more impactful ways to reach European oncologists with the data they need.
#ISMPP #ISMPPEurope #MedPubs #Oncology #ScientificComms #HCPEngagement
We're looking forward to next week's Disruptive Technology for Clinical Trials Europe 2026 meeting in London. If you'll be in attendance, email contact@lumanity.com to meet. buff.ly/HR8rC7J
#ClinicalTrialsEurope #RWE #ClinicalResearch #PatientSafety #ClinicalDevelopment
#ClinicalTrialsEurope #RWE #ClinicalResearch #PatientSafety #ClinicalDevelopment
January 20, 2026 at 12:01 PM
We're looking forward to next week's Disruptive Technology for Clinical Trials Europe 2026 meeting in London. If you'll be in attendance, email contact@lumanity.com to meet. buff.ly/HR8rC7J
#ClinicalTrialsEurope #RWE #ClinicalResearch #PatientSafety #ClinicalDevelopment
#ClinicalTrialsEurope #RWE #ClinicalResearch #PatientSafety #ClinicalDevelopment
Whether you’re preparing for a Medicare Drug Price Negotiation in the US or a Joint Clinical Assessment in the EU, one factor will make or break success: robust, early, and strategic evidence generation. Our “2025 in Review” distills the lessons that matter most: buff.ly/6Ev0nXJ
#MarketAccess #HEOR
#MarketAccess #HEOR
January 19, 2026 at 12:02 PM
Whether you’re preparing for a Medicare Drug Price Negotiation in the US or a Joint Clinical Assessment in the EU, one factor will make or break success: robust, early, and strategic evidence generation. Our “2025 in Review” distills the lessons that matter most: buff.ly/6Ev0nXJ
#MarketAccess #HEOR
#MarketAccess #HEOR
Just one week to go until #ISMPPEurope 2026!
Be sure to catch our poster "Optimizing data dissemination for European oncologists: evidence-based selection and content enhancement" and connect with us at stand #5.
#MedPubs #MedComms #ISMPP #Oncology #ScientificCommunications #MedicalPublications
Be sure to catch our poster "Optimizing data dissemination for European oncologists: evidence-based selection and content enhancement" and connect with us at stand #5.
#MedPubs #MedComms #ISMPP #Oncology #ScientificCommunications #MedicalPublications
January 19, 2026 at 8:01 AM
Just one week to go until #ISMPPEurope 2026!
Be sure to catch our poster "Optimizing data dissemination for European oncologists: evidence-based selection and content enhancement" and connect with us at stand #5.
#MedPubs #MedComms #ISMPP #Oncology #ScientificCommunications #MedicalPublications
Be sure to catch our poster "Optimizing data dissemination for European oncologists: evidence-based selection and content enhancement" and connect with us at stand #5.
#MedPubs #MedComms #ISMPP #Oncology #ScientificCommunications #MedicalPublications
Access key strategies to ensure your organization makes the most of every #FDA interaction, shape development pathways, clarify regulatory expectations, and meaningfully reduce program risk: buff.ly/9zkotWO
#DrugDevelopment #RegulatoryAffairs #ClinicalDevelopment
#DrugDevelopment #RegulatoryAffairs #ClinicalDevelopment
January 15, 2026 at 8:03 PM
Access key strategies to ensure your organization makes the most of every #FDA interaction, shape development pathways, clarify regulatory expectations, and meaningfully reduce program risk: buff.ly/9zkotWO
#DrugDevelopment #RegulatoryAffairs #ClinicalDevelopment
#DrugDevelopment #RegulatoryAffairs #ClinicalDevelopment
#ICYMI: EU HTAR One Year On. Suzette Matthijsse, JCA Lead at Lumanity, and Neil Grubert, independent market access specialist, share insights from the first year of EU HTAR and what’s ahead.
Watch the on-demand recording here: lumanity.com/perspectives...
Watch the on-demand recording here: lumanity.com/perspectives...
January 15, 2026 at 4:00 PM
#ICYMI: EU HTAR One Year On. Suzette Matthijsse, JCA Lead at Lumanity, and Neil Grubert, independent market access specialist, share insights from the first year of EU HTAR and what’s ahead.
Watch the on-demand recording here: lumanity.com/perspectives...
Watch the on-demand recording here: lumanity.com/perspectives...
Will you be at the upcoming #Pharma #MarketResearch Conference (PMRC) in a few weeks?
If so, be sure to stop by our exhibit booth and connect with our experts on site including Michael Harris or e-mail us at contact@lumanity.com to schedule time to meet.
#PMRC #MarketResearch
If so, be sure to stop by our exhibit booth and connect with our experts on site including Michael Harris or e-mail us at contact@lumanity.com to schedule time to meet.
#PMRC #MarketResearch
January 14, 2026 at 8:01 PM
Will you be at the upcoming #Pharma #MarketResearch Conference (PMRC) in a few weeks?
If so, be sure to stop by our exhibit booth and connect with our experts on site including Michael Harris or e-mail us at contact@lumanity.com to schedule time to meet.
#PMRC #MarketResearch
If so, be sure to stop by our exhibit booth and connect with our experts on site including Michael Harris or e-mail us at contact@lumanity.com to schedule time to meet.
#PMRC #MarketResearch
Are you prepared for how the FDA plans to drastically reduce animal testing and how it may impact your pipeline? Check out Lumanity's perspective in a recent pharmaphorum article: buff.ly/axmMlIv
#DrugDevelopment #RegulatoryStrategy #NAMs #Oncology #FDA #PharmaInnovation
#DrugDevelopment #RegulatoryStrategy #NAMs #Oncology #FDA #PharmaInnovation
January 14, 2026 at 4:00 PM
Are you prepared for how the FDA plans to drastically reduce animal testing and how it may impact your pipeline? Check out Lumanity's perspective in a recent pharmaphorum article: buff.ly/axmMlIv
#DrugDevelopment #RegulatoryStrategy #NAMs #Oncology #FDA #PharmaInnovation
#DrugDevelopment #RegulatoryStrategy #NAMs #Oncology #FDA #PharmaInnovation
ICYMI, our recent blog addresses why investing early in a comprehensive, structured approach is the first step to significantly improving the odds of #clinical, #regulatory, and #commercial success, and ultimate long-term value creation, for your asset buff.ly/cSECH0t
#IndicationStrategy #BioPharma
#IndicationStrategy #BioPharma
January 12, 2026 at 12:01 PM
ICYMI, our recent blog addresses why investing early in a comprehensive, structured approach is the first step to significantly improving the odds of #clinical, #regulatory, and #commercial success, and ultimate long-term value creation, for your asset buff.ly/cSECH0t
#IndicationStrategy #BioPharma
#IndicationStrategy #BioPharma
2025 brought unprecedented change and unprecedented opportunity, from US drug pricing reforms to Europe’s HTA harmonization. Our article “2025 in Review” is your guide to turning trends into advantage in 2026 and beyond. Read the article here: buff.ly/6Ev0nXJ
#MarketAccess #HEOR #HTA
#MarketAccess #HEOR #HTA
January 12, 2026 at 8:01 AM
2025 brought unprecedented change and unprecedented opportunity, from US drug pricing reforms to Europe’s HTA harmonization. Our article “2025 in Review” is your guide to turning trends into advantage in 2026 and beyond. Read the article here: buff.ly/6Ev0nXJ
#MarketAccess #HEOR #HTA
#MarketAccess #HEOR #HTA
ICYMI, here are 5 of our must-read publications to help you:
• Anticipate and overcome regulatory roadblocks
• Optimize development strategies
• Accelerate approvals and market access
Read on: lumanity.com/perspectives...
#Regulatory #ClinicalAndRegulatory #Insights #DrugDevelopment #FDA
• Anticipate and overcome regulatory roadblocks
• Optimize development strategies
• Accelerate approvals and market access
Read on: lumanity.com/perspectives...
#Regulatory #ClinicalAndRegulatory #Insights #DrugDevelopment #FDA
January 8, 2026 at 4:02 PM
ICYMI, here are 5 of our must-read publications to help you:
• Anticipate and overcome regulatory roadblocks
• Optimize development strategies
• Accelerate approvals and market access
Read on: lumanity.com/perspectives...
#Regulatory #ClinicalAndRegulatory #Insights #DrugDevelopment #FDA
• Anticipate and overcome regulatory roadblocks
• Optimize development strategies
• Accelerate approvals and market access
Read on: lumanity.com/perspectives...
#Regulatory #ClinicalAndRegulatory #Insights #DrugDevelopment #FDA
ICYMI, our latest webinar covers #EarlyAssetStrategy decisions having an outsized impact on long-term success, anticipated #Market and #Regulatory shifts, and embedding #PatientInsights to set the stage for sustained success. Watch buff.ly/i0IXtJs
#RWE #LaunchStrategy
#RWE #LaunchStrategy
January 7, 2026 at 12:01 PM
ICYMI, our latest webinar covers #EarlyAssetStrategy decisions having an outsized impact on long-term success, anticipated #Market and #Regulatory shifts, and embedding #PatientInsights to set the stage for sustained success. Watch buff.ly/i0IXtJs
#RWE #LaunchStrategy
#RWE #LaunchStrategy
Watch the full interview, download the infographic, and read the white paper on navigating evidence transportability in a global RWE landscape: buff.ly/ebw2AoN
#HTA #RealWorldEvidence #EvidenceTransportability #RWEStrategy #RWD
#HTA #RealWorldEvidence #EvidenceTransportability #RWEStrategy #RWD
January 7, 2026 at 8:01 AM
Watch the full interview, download the infographic, and read the white paper on navigating evidence transportability in a global RWE landscape: buff.ly/ebw2AoN
#HTA #RealWorldEvidence #EvidenceTransportability #RWEStrategy #RWD
#HTA #RealWorldEvidence #EvidenceTransportability #RWEStrategy #RWD
Happy New Year to all of our passionate, collaborative, and enthusiastic clients, staff, and followers.
We are excited for the start of the new year and look forward to working with all of you in 2026!
#NewYears #NewYears2026 #HappyNewYear
We are excited for the start of the new year and look forward to working with all of you in 2026!
#NewYears #NewYears2026 #HappyNewYear
January 2, 2026 at 1:30 PM
Happy New Year to all of our passionate, collaborative, and enthusiastic clients, staff, and followers.
We are excited for the start of the new year and look forward to working with all of you in 2026!
#NewYears #NewYears2026 #HappyNewYear
We are excited for the start of the new year and look forward to working with all of you in 2026!
#NewYears #NewYears2026 #HappyNewYear
In part 2 of our podcast, our experts discuss how companies can move beyond information overload to build true #CompetitiveReadiness through focus, collaboration, and action. Tune in: buff.ly/Hoblg2Q
#LaunchReadiness #LaunchExcellence #CompetitiveStrategy #Pharma #Biotech
#LaunchReadiness #LaunchExcellence #CompetitiveStrategy #Pharma #Biotech
December 30, 2025 at 12:01 PM
In part 2 of our podcast, our experts discuss how companies can move beyond information overload to build true #CompetitiveReadiness through focus, collaboration, and action. Tune in: buff.ly/Hoblg2Q
#LaunchReadiness #LaunchExcellence #CompetitiveStrategy #Pharma #Biotech
#LaunchReadiness #LaunchExcellence #CompetitiveStrategy #Pharma #Biotech
We had a blast celebrating the end of the year and holiday season with colleagues in Boston earlier this week.
We wish everyone a peaceful and bright end of 2025!
We wish everyone a peaceful and bright end of 2025!
December 19, 2025 at 7:01 PM
We had a blast celebrating the end of the year and holiday season with colleagues in Boston earlier this week.
We wish everyone a peaceful and bright end of 2025!
We wish everyone a peaceful and bright end of 2025!
From shifting #FDA priorities to complexities of #RareAndOrphan #DrugDevelopment, 2025 has been full of challenges — and opportunities. Explore actionable insights to navigate #Regulatory uncertainty, reduce risk, and maximize value in your programs: buff.ly/HyhctET
December 16, 2025 at 12:01 PM
From shifting #FDA priorities to complexities of #RareAndOrphan #DrugDevelopment, 2025 has been full of challenges — and opportunities. Explore actionable insights to navigate #Regulatory uncertainty, reduce risk, and maximize value in your programs: buff.ly/HyhctET
Generating #RWE in #SpinalMuscularAtrophy (#SMA) faces hurdles with evolving standard of care, inconsistent outcomes measurement, severity baseline, and the need for long-term follow-up. Test your objectives with us: buff.ly/Qj6Z6Uq
#HCRU #SpinalCare #RealWorldEvidence
#HCRU #SpinalCare #RealWorldEvidence
December 15, 2025 at 8:00 AM
Generating #RWE in #SpinalMuscularAtrophy (#SMA) faces hurdles with evolving standard of care, inconsistent outcomes measurement, severity baseline, and the need for long-term follow-up. Test your objectives with us: buff.ly/Qj6Z6Uq
#HCRU #SpinalCare #RealWorldEvidence
#HCRU #SpinalCare #RealWorldEvidence